Covered recipient · General Payments record
CHARLES Y PENG
Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease
General Payments · PY2018–2024
$681.25
- Reported across 27 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $350.31 | 10 |
| Education | $81.36 | 3 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Medtronic, Inc. | $172.56 | 1 |
| Merck Sharp & Dohme Corporation | $76.51 | 2 |
| GlaxoSmithKline, LLC. | $47.07 | 3 |
| Insmed, Inc. | $34.46 | 2 |
| Grifols USA, LLC | $24.33 | 1 |
| Acerta Pharma LLC | $21.72 | 1 |
| BAXTER HEALTHCARE | $20.66 | 1 |
| Actelion Pharmaceuticals US, Inc. | $17.43 | 1 |
| GENZYME CORPORATION | $16.93 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Actelion Pharmaceuticals US, Inc. | $17.43 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078906181 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.72 | 10/22/2024 | Education | Undisputed | 01/23/2026 | 1104673607 | CMS |
| Baxter Healthcare | $20.66 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120653743 | CMS |
| GENZYME CORPORATION | $16.93 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139953008 | CMS |
| GlaxoSmithKline, LLC. | $18.50 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116463194 | CMS |
| GlaxoSmithKline, LLC. | $13.18 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115728682 | CMS |
| GlaxoSmithKline, LLC. | $15.39 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116277596 | CMS |
| Grifols USA, LLC | $24.33 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124744902 | CMS |
| Insmed, Inc. | $16.24 | 10/28/2024 | Education | Undisputed | 01/23/2026 | 1089558274 | CMS |
| Insmed, Inc. | $18.22 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089567549 | CMS |
| Medtronic, Inc. | $172.56 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119266566 | CMS |
| Merck Sharp & Dohme LLC | $43.40 | 08/27/2024 | Education | Undisputed | 01/23/2026 | 1141827930 | CMS |
| Merck Sharp & Dohme LLC | $33.11 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141827932 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.